H
Hangzhou Biotest Biotech Co Ltd
SSE:688767
Hangzhou Biotest Biotech Co Ltd
SSE:688767
Price:
30.81
CNY
-2.13%
Market Closed
Market Cap:
¥4.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Hangzhou Biotest Biotech Co Ltd
SSE:688767
|
CN |
|
Fidelity National Financial Inc
NYSE:FNF
|
US |
|
H
|
Hyundai Green Food Co Ltd
KRX:005440
|
KR |
Multiples-Based Value
The Multiples-Based Value for Hangzhou Biotest Biotech Co Ltd (688767) under the Base Case is 16.78 CNY. Compared with the current market price of 30.81 CNY, the stock appears Overvalued by 46%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
16.78
CNY
Overvaluation 46%
H
Multiples Across Competitors
Competitors Multiples
Hangzhou Biotest Biotech Co Ltd Competitors
Hangzhou Biotest Biotech Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
H
|
Hangzhou Biotest Biotech Co Ltd
SSE:688767
|
4.6B CNY | 9.6 | 44.9 | 49.1 | 49.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 6 | 87.3 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5 | 23.9 | 13.9 | 13.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD | 9.2 | 27.9 | 20.9 | 21.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD | 5.6 | 17.9 | 13.4 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
